跳至主要内容
临床试验/NL-OMON38540
NL-OMON38540已完成2 期

Plaque stabilization and restoration of vascular function by bioresorbable vascular scaffold in acute coronary syndrome prone patients - ABSORB-PREVENT

Canisius Wilhelmina Ziekenhuis0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Symptomatic patients between the age of 18 and 80 years
  • - Morise Risk score of *9 (intermediate or high risk) but no proven ischemia (no positive troponin or ST-elevation)
  • - Intermediate coronary lesion on CT scan (50-70% based on CT estimate) and a plaque with at least two of the following vulnerability criteria: Napkin ring sign, positive remodeling, low attenuation and spotty calcification
  • - FFR negative lesion at coronary angiogram
  • - Vessel diameter *2.5 mm on visual estimate

排除标准

  • - High calcium score on CT scan preventing adequate evaluation of the coronary lesion.
  • - Lesions located in a coronary vessels previously stented.
  • - Left main (>50%) or known three vessel disease.
  • - Intolerance to Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Heparine or Everolimus and known true anaphylaxis to prior contrast media or known bleeding diathesis or known coagulopathy.

研究者

发起方
Canisius Wilhelmina Ziekenhuis

相似试验